HER2-enriched-like breast cancer (Zhang, 2020)

STUDY TITLE: Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

SUMMARY: Discovery of novel genetic variants associated with HER2-enriched-like breast cancer.

OVERVIEW: Breasts are complex structures with multiple cell types which can give rise to multiple types of cancer. Breast cancers are classified by what receptors cancer cells have on the outside. This classification is helpful for predicting outcomes and effective treatments. Breast cancers that use the human epidermal growth factor 2 receptor (HER2+) make up 15-30% of all breast cancers. HER2+ breast cancers are historically associated with poor prognosis and an increased recurrence, but there are now new drugs that specifically target the HER2 receptor and improve survival. HER2-enriched-like cancers have the HER2 receptor but do not have other hormone receptors like receptors for estrogen or progesterone. This genome-wide association study examined nearly 266,000 individuals of European ancestry to identify genetic variants associated with different breast cancer types, including HER2-enriched-like cancers. In total, the researchers identified 330 genomic regions associated with breast cancer types and used them to calculate polygenic scores.

DID YOU KNOW? Modern therapies are able to specifically target cells that express HER2. This has dramatically increased the survival rate for patients with HER2+ breast cancer. [SOURCE]

SAMPLE RESULTS: Learn more about the Nebula Research Library.

her2-like breast cancer sample results

HER2-ENRICHED BREAST CANCER-ASSOCIATED VARIANTS: rs9712235, rs4602255, rs188092014, rs13256025, rs13277568, rs11652463, rs495367, rs7924772, rs78378222, rs206435, rs17215231, rs612683, rs616488, rs7513707, rs12406858, rs637868, rs11249433, rs111458676, rs11205303, rs12091730, rs2992756, rs35383942, rs6686987, rs7514172, rs2785646, rs2576261, rs11118563, rs72755295, rs4233486, rs114282204, rs707475, rs2151842, rs78425380, rs6746250, rs17625845, rs10164550, rs10179592, rs17726078, rs1550622, rs2356656, rs6743383, rs10197246, rs4442975, rs11693806, rs3791977, rs4676356, rs6725517, rs12472404, rs4322799, rs1036759, rs9882792, rs552647, rs112476261, rs17838698, rs56387622, rs6762558, rs2886671, rs9825432, rs13066793, rs639355, rs62331150, rs56039025, rs13147907, rs10012017, rs17014016, rs17157372, rs335160, rs1428387, rs10069690, rs6860806, rs62329727, rs1432679, rs17611291, rs10074269, rs6864691, rs4868701, rs116095464, rs187108781, rs4613718, rs10941679, rs17343002, rs889310, rs16886165, rs76250845, rs11949391, rs113778879, rs3010266, rs157557, rs418053, rs2121348, rs6913578, rs60954078, rs851984, rs6904031, rs910416, rs3819405, rs9364472, rs6940159, rs12211970, rs9358466, rs34196306, rs111342015, rs73754909, rs71559437, rs7800548, rs12706954, rs68056147, rs62485509, rs7971, rs289997, rs74765302, rs13244925, rs17268829, rs4439053, rs111963714, rs62517052, rs12546444, rs13267382, rs62526620, rs35542655, rs12541094, rs7842619, rs12550713, rs10096351, rs1016578, rs7830152, rs66823261, rs1028016, rs310295, rs9693444, rs13365225, rs1511243, rs72658084, rs1533366, rs10816625, rs13294895, rs7848334, rs630965, rs1895062, rs3861871, rs17694493, rs4880038, rs10975870, rs10120432, rs10885405, rs12250948, rs45631580, rs45631563, rs10796139, rs7072776, rs10764337, rs2384736, rs10995201, rs6479868, rs111833376, rs719338, rs4980029, rs7125780, rs610437, rs625145, rs7121616, rs7939702, rs11822830, rs10832963, rs4980386, rs4472923, rs7394715, rs10838267, rs77047825, rs12287832, rs10896047, rs35039974, rs661204, rs78540526, rs6597981, rs2454399, rs12422552, rs788458, rs7297051, rs2277339, rs17356907, rs56404467, rs11571833, rs9315973, rs12870942, rs2181965, rs4983544, rs34914085, rs2253012, rs2588809, rs11624333, rs941764, rs78440108, rs144767203, rs187010898, rs4774565, rs8042593, rs35874463, rs8035987, rs2290202, rs34872983, rs75753503, rs11076805, rs35668161, rs4784227, rs55872725, rs6499648, rs7184573, rs28539243, rs12709163, rs7500067, rs9931038, rs12449271, rs79461387, rs150537328, rs11296, rs17881320, rs149370081, rs2787486, rs745570, rs16976596, rs11665269, rs1111207, rs527616, rs8092192, rs72931898, rs9954058, rs9952980, rs117922601, rs56069439, rs10164323, rs56681946, rs4399645, rs1172821, rs1154723, rs6030585, rs13039563, rs16991615, rs2822999, rs2823130, rs2403907, rs4818836, rs9798754, rs17879961, rs5997390, rs34134147, rs132289, rs5750715, rs9611990, rs112855987, rs28512361

ADDITIONAL RESOURCES:
HER2 positive breast cancer: everything you must know (Video)
HER2 status

YOU MAY ALSO BE INTERESTED IN:
Luminal A-like breast cancer (Zhang, 2020)
Luminal B/HER2-negative-like breast cancer (Zhang, 2020)
Luminal B-like breast cancer (Zhang, 2020)
Triple-negative breast cancer (Zhang, 2020)
Breast cancer (Shu, 2020)

WEEKLY UPDATE: June 2, 2020


Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on print
Share on email
en_USEnglish
fr_FRFrench es_ESSpanish ru_RURussian jaJapanese zh_CNChinese en_USEnglish